Tissue Diagnostic Market

Tissue Diagnostic Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

# Pages:

140

Base Year:

2022

Mar - 2022

Format:

Report Code:

VMR-1379

Segments Covered

By Product Consumables, Instruments
By Technology Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology and Workflow Management, Special Staining
By Disease Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Other Diseases
By End User Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, Other End Users

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 3831.90 Million
Revenue 2030:	USD 6107.47 Million
Revenue CAGR (2023 - 2030):	6.00%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Tissue Diagnostic Market - Segment Analysis
1. Overview
2. Global Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. Global Tissue Diagnostic Market - by Product
  1. By Consumables
  2. By Instruments
4. Global Tissue Diagnostic Market - by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. Global Tissue Diagnostic Market - by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. Global Tissue Diagnostic Market - by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. Global Tissue Diagnostic Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Tissue Diagnostic Market - Segment Analysis
1. Overview
2. North America Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. North America Tissue Diagnostic Market, by Product
  1. By Consumables
  2. By Instruments
4. North America Tissue Diagnostic Market, by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. North America Tissue Diagnostic Market, by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. North America Tissue Diagnostic Market, by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. North America Tissue Diagnostic Market, by Country
  1. U.S.
    1. U.S. Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. U.S. Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. U.S. Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. U.S. Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  2. Canada
    1. Canada Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Canada Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Canada Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Canada Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  3. Mexico
    1. Mexico Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Mexico Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Mexico Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Mexico Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
Europe Tissue Diagnostic Market - Segment Analysis
1. Overview
2. Europe Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. Europe Tissue Diagnostic Market, by Product
  1. By Consumables
  2. By Instruments
4. Europe Tissue Diagnostic Market, by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. Europe Tissue Diagnostic Market, by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. Europe Tissue Diagnostic Market, by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. Europe Tissue Diagnostic Market, by Country
  1. Germany
    1. Germany Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Germany Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Germany Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Germany Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  2. UK
    1. UK Market, By Product
      1. By Consumables
      2. By Instruments
    2. UK Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. UK Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. UK Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  3. France
    1. France Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. France Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. France Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. France Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  4. Spain
    1. Spain Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Spain Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Spain Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Spain Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  5. Italy
    1. Italy Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Italy Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Italy Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Italy Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  6. BENELUX
    1. BENELUX Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. BENELUX Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. BENELUX Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. BENELUX Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  7. Rest of Europe
    1. Rest Of Europe Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Rest Of Europe Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Rest Of Europe Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Rest Of Europe Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
Asia Pacific Tissue Diagnostic Market - Segment Analysis
1. Overview
2. Asia Pacific Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. Asia Pacific Tissue Diagnostic Market, by Product
  1. By Consumables
  2. By Instruments
4. Asia Pacific Tissue Diagnostic Market, by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. Asia Pacific Tissue Diagnostic Market, by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. Asia Pacific Tissue Diagnostic Market, by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. Asia Pacific Tissue Diagnostic Market, by Country
  1. China
    1. China Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. China Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. China Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. China Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  2. Japan
    1. Japan Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Japan Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Japan Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Japan Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  3. India
    1. India Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. India Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. India Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. India Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  4. South Korea
    1. South Korea Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. South Korea Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. South Korea Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. South Korea Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  5. South East Asia
    1. South East Asia Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. South East Asia Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. South East Asia Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. South East Asia Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Rest of Asia Pacific Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Rest of Asia Pacific Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Rest of Asia Pacific Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
Latin America Tissue Diagnostic Market - Segment Analysis
1. Overview
2. Latin America Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. Latin America Tissue Diagnostic Market, by Product
  1. By Consumables
  2. By Instruments
4. Latin America Tissue Diagnostic Market, by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. Latin America Tissue Diagnostic Market, by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. Latin America Tissue Diagnostic Market, by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. Latin America Tissue Diagnostic Market, by Country
  1. Brazil
    1. Brazil Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Brazil Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Brazil Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Brazil Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  2. Argentina
    1. Argentina Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Argentina Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Argentina Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Argentina Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  3. Rest of Latin America
    1. Rest of Latin America Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Rest of Latin America Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Rest of Latin America Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Rest of Latin America Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
Middle East & Africa Tissue Diagnostic Market - Segment Analysis
1. Overview
2. Middle East & Africa Tissue Diagnostic Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Tissue Diagnostic Market, by Product
  1. By Consumables
  2. By Instruments
4. Middle East & Africa Tissue Diagnostic Market, by Technology
  1. By Immunohistochemistry (IHC)
  2. By In Situ Hybridization (ISH)
  3. By Digital Pathology and Workflow Management
  4. By Special Staining
5. Middle East & Africa Tissue Diagnostic Market, by Disease
  1. By Breast Cancer
  2. By Gastric Cancer
  3. By Lymphoma
  4. By Prostate Cancer
  5. By Non-Small Cell Lung Cancer (NSCLC)
  6. By Other Diseases
6. Middle East & Africa Tissue Diagnostic Market, by End User
  1. By Hospitals
  2. By Research Laboratories
  3. By Pharmaceutical Companies
  4. By Contract Research Organizations
  5. By Other End Users
7. Middle East & Africa Tissue Diagnostic Market, by Country
  1. GCC Countries
    1. GCC Countries Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. GCC Countries Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. GCC Countries Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. GCC Countries Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  2. South Africa
    1. South Africa Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. South Africa Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. South Africa Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. South Africa Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Tissue Diagnostic Market, By Product
      1. By Consumables
      2. By Instruments
    2. Rest of Middle East & Africa Tissue Diagnostic Market, By Technology
      1. By Immunohistochemistry (IHC)
      2. By In Situ Hybridization (ISH)
      3. By Digital Pathology and Workflow Management
      4. By Special Staining
    3. Rest of Middle East & Africa Tissue Diagnostic Market, By Disease
      1. By Breast Cancer
      2. By Gastric Cancer
      3. By Lymphoma
      4. By Prostate Cancer
      5. By Non-Small Cell Lung Cancer (NSCLC)
      6. By Other Diseases
    4. Rest of Middle East & Africa Tissue Diagnostic Market, By End User
      1. By Hospitals
      2. By Research Laboratories
      3. By Pharmaceutical Companies
      4. By Contract Research Organizations
      5. By Other End Users
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Roche (Switzerland)
2. Danaher (US)
3. Thermo Fisher Scientific (US)
4. Abbott (US)
5. Agilent Technologies (US)
6. ABCAM (UK)
7. Merck KGAA (Germany)
8. BD (US)
9. Hologic (US)
10. Qiagen (Germany)
11. Bio Rad (US)
12. Biomeriux (France)
13. Sakura Fientek Japan (Japan)
14. BioSB (US)
15. Biogenex (US)
16. Cell Signaling Technology (US)
17. Histoline Laboratories (Italy)
18. Slee Medical GMBH (Germany)
19. Amos Scientific PTY Ltd (Australia)
20. Jinhua Yidi Medical Appliance Co.Ltd (China)
21. Medite GMBH (Germany)
22. Cellpath Ltd(UK)
23. Dipath S.P.A. (Italy).
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 16-Mar-2022

Tissue Diagnostic Market to Reach 5,157.33 USD Million by 2028

FAQ

Frequently Asked Question

What is the global demand for Tissue Diagnostic in terms of revenue?

The global Tissue Diagnostic valued at USD 3831.90 Million in 2022 and is expected to reach USD 6107.47 Million in 2030 growing at a CAGR of 6.00%.

Which are the prominent players in the market?

The prominent players in the market are Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), BD (US), Hologic (US), Qiagen (Germany), Bio Rad (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific PTY Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK), Dipath S.P.A. (Italy)..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 6.00% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Tissue Diagnostic include
- rising cancer prevalence, improved infrastructure for cancer diagnostics, rising healthcare spending, and various technological advancements

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Tissue Diagnostic in 2022.

Tissue Diagnostic Market

Tissue Diagnostic Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Tissue Diagnostic in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Tissue Diagnostic Market

Tissue Diagnostic Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Tissue Diagnostic in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Tissue Diagnostic Market

Vantage Point Interactive Dashboard